Technical Event
Pascal Rol Keynote Address
27 January 2024 • 11:00 AM - 12:00 PM PST | Moscone Center, Room 156 (Upper Mezzanine South)
The Pascal Rol keynote presentation was established to promote the exchange of ideas between clinicians with a technological need and engineers interested in solving problems in ophthalmology. The invited lecture is sponsored by the Pascal Rol Foundation.
11:00 AM - 11:15 AM: Introduction
Daniel X. Hammer, U.S. Food and Drug Administration (United States)
11:15 AM - 12:00 PM: Spying on retina microworlds: Synergizing dynamic enface OCT and quad-fusion adaptive optics SLO imaging
Richard B. Rosen, Icahn School of Medicine at Mount Sinai (United States)
In the last quarter century, enface OCT and adaptive optics SLO imaging have exploded the ophthalmoscopic perspective, transporting clinicians through keyholes to new dimensions of retinal visualization, inviting revolutionary advances in diagnosis and therapy. To bridge the clinic - laboratory divide we have developed custom instruments to further survey and probe pathologies captured with commercial instruments, expanding our clinical understanding along with our visualization. These vistas offer a glimpse of microworlds yet to be navigated.
Dr. Richard B.Rosen is the Belinda and Gerald Pierce Distinguished Chair of Ophthalmology and Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai. He is Chief of Retina of the Mount Sinai Health System and Retina Fellowship Director, as well as Vice Chairman, Director of Ophthalmology Research, and Surgeon Director at the New York Eye and Ear Infirmary. He is also Honorary Professor in Applied Optics at the University of Kent in Canterbury, UK., where he was awarded an Honorary Doctorate in Medical Physics. Dr. Rosen received his bachelor’s degree in psychology and anthropology at the University of Michigan and his MD from the University of Miami School of Medicine. Dr. Rosen’s research interests include new treatments for macular degeneration and diabetic retinopathy, innovations in diagnostic retinal imaging, and vitreoretinal surgical instrumentation. He helped pioneer the introduction of multimodal enface OCT/SLO, championed Adaptive Optics SLO Imaging for clinical applications at, pioneered quantitative capillary density mapping for OCT angiography, and is currently developing cellular imaging using clinical OCT along with robotic tools for vitreoretinal surgery.
11:00 AM - 11:15 AM: Introduction
Daniel X. Hammer, U.S. Food and Drug Administration (United States)
11:15 AM - 12:00 PM: Spying on retina microworlds: Synergizing dynamic enface OCT and quad-fusion adaptive optics SLO imaging
Richard B. Rosen, Icahn School of Medicine at Mount Sinai (United States)
In the last quarter century, enface OCT and adaptive optics SLO imaging have exploded the ophthalmoscopic perspective, transporting clinicians through keyholes to new dimensions of retinal visualization, inviting revolutionary advances in diagnosis and therapy. To bridge the clinic - laboratory divide we have developed custom instruments to further survey and probe pathologies captured with commercial instruments, expanding our clinical understanding along with our visualization. These vistas offer a glimpse of microworlds yet to be navigated.
Dr. Richard B.Rosen is the Belinda and Gerald Pierce Distinguished Chair of Ophthalmology and Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai. He is Chief of Retina of the Mount Sinai Health System and Retina Fellowship Director, as well as Vice Chairman, Director of Ophthalmology Research, and Surgeon Director at the New York Eye and Ear Infirmary. He is also Honorary Professor in Applied Optics at the University of Kent in Canterbury, UK., where he was awarded an Honorary Doctorate in Medical Physics. Dr. Rosen received his bachelor’s degree in psychology and anthropology at the University of Michigan and his MD from the University of Miami School of Medicine. Dr. Rosen’s research interests include new treatments for macular degeneration and diabetic retinopathy, innovations in diagnostic retinal imaging, and vitreoretinal surgical instrumentation. He helped pioneer the introduction of multimodal enface OCT/SLO, championed Adaptive Optics SLO Imaging for clinical applications at, pioneered quantitative capillary density mapping for OCT angiography, and is currently developing cellular imaging using clinical OCT along with robotic tools for vitreoretinal surgery.